CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-27 | Reardon Andrew CHIEF LEGAL OFFICER & | Grant or award · Employee Stock Option (right to buy) | +29,272 | 29,272 | ||
| 2024-02-27 | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | Grant or award | +14,416 | 103,861 | ||
| 2024-02-27 | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | Grant or award · Employee Stock Option (right to buy) | +58,544 | 58,544 | ||
| 2024-02-27 | Espinoza Octavio Chief Financial Officer | Grant or award | +7,208 | 28,631 | ||
| 2024-02-27 | Espinoza Octavio Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +29,272 | 29,272 | ||
| 2024-02-27 | Davis Todd C CHIEF EXECUTIVE OFFICER | Grant or award | +32,436 | 104,145 | ||
| 2024-02-27 | Davis Todd C CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +131,723 | 131,723 | ||
| 2024-02-15 | Reardon Andrew CHIEF LEGAL OFFICER & | Shares withheld for taxes | −593 | $74.65 | $44K | 14,997 |
| 2024-02-15 | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | Shares withheld for taxes | −4,778 | $74.65 | $357K | 89,445 |
| 2024-02-15 | Espinoza Octavio Chief Financial Officer | Shares withheld for taxes | −1,479 | $74.65 | $110K | 21,423 |
| 2024-02-15 | Davis Todd C CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −1,381 | $74.65 | $103K | 71,709 |
| 2024-01-02 | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | Shares withheld for taxes | −2,917 | $72.31 | $211K | 94,223 |
| 2023-12-29 | Reardon Andrew CHIEF LEGAL OFFICER & | Other acquisition | +179 | $60.71 | $11K | 15,590 |
| 2023-12-05 | Espinoza Octavio Chief Financial Officer | Shares withheld for taxes | −1,269 | $59.61 | $76K | 22,902 |
| 2023-12-05 | Korenberg Matthew E PRESIDENT & CHIEF OPERATING | Shares withheld for taxes | −1,984 | $59.61 | $118K | 97,140 |
| 2023-10-01 | Espinoza Octavio Chief Financial Officer | Shares withheld for taxes | −346 | $59.92 | $21K | 24,171 |
| 2023-09-22 | Zimmermann Martine Director | Grant or award | +2,285 | 2,285 | ||
| 2023-09-22 | Zimmermann Martine Director | Grant or award · Employee Stock Option (right to buy) | +11,345 | 11,345 | ||
| 2023-09-22 | Davis Todd C CHIEF EXECUTIVE OFFICER | Purchase | +4,000 | $59.38 | $238K | 73,090 |
| 2023-08-10 | Reardon Andrew CHIEF LEGAL OFFICER & | Shares withheld for taxes | −897 | $68.73 | $62K | 15,411 |
Page 24 of 43 · 858 trades